Disclosure statement
No specific funding or conflicts of interest relating to this work were reported.
References
  1. R. Nair, A. Maseeh. Vitamin D: The “sunshine” vitamin. J Pharmacol Pharmacother . 3, 118-126, (2012) Abstract/FREE Full Text
  2. K. S. Vimaleswaran, D. J. Berry, C. Lu, E. Tikkanen, S. Pilz, L. T. Hiraki, J. D. Cooper, Z. Dastani, R. Li, D. K. Houston, A. R. Wood, K.I. Michaëlsson, L. Vandenput, L. Zgaga, L. M. Yerges-Armstrong, M. I. McCarthy, J Dupuis, M. Kaakinen, M. E. Kleber, K. Jameson, N. Arden, O. Raitakari, J. Viikari, K. K. Lohman, L. Ferrucci, H. Melhus, E. Ingelsson, L. Byberg, L. Lind, M. Lorentzon, V. Salomaa, H. Campbell, M. Dunlop, B. D. Mitchell, K. Herzig, A. Pouta, A. Hartikainen, E. A. Streeten, E. Theodoratou, A. Jula, N. J. Wareham, C. Ohlsson, T. M. Frayling, S. B. Kritchevsky, T. D. Spector, J. B. Richards, T. Lehtimäki, W.H. Ouwehand, P. Kraft, C. Cooper, W. März, C. Power, R. J. F. Loos, T. J. Wang, M. Järvelin, J. C. Whittaker, A. D. Hingorani, E. Hyppönen. Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts. PLOS Medicine . 10(2), e1001383. (2013) Abstract/FREE Full Text
  3. M. Suthar. NHS Audit Reveals Two-Thirds of Critical Coronavirus Patients Overweight. Diabetes in Control . (2020) Abstract/FREE Full Text
  4. W. Dietz, C. Santos‐Burgoa. Obesity and its Implications for COVID‐19 Mortality. Obesity (Silver Spring) , (2020). Abstract/FREE Full Text
  5. World Health Organization Fact Sheet Obesity and Overweight. 2017 Abstract/FREE Full Text
  6. R. Huttunen, J. Syrjänen. Obesity and the risk and outcome of infection. International Journal of Obesity . 37, 333–340. (2013) Abstract/FREE Full Text
  7. P. Sakharkar, S. Deb, D. Vu. Vitamin D Receptor (VDR) Gene Polymorphism: Implications on Non-Bone Diseases. J Basic Clin Pharma . 8, S06-S10. (2017) Abstract/FREE Full Text
  8. M. Laplana, J. Luis, R. J. Fibla. Vitamin D Receptor polymorphisms and risk of enveloped virus infection: A meta-analysis. Gene . 678, 384-394 (2018) Abstract/FREE Full Text
  9. A.S. Vanherwegen, C. Gysemans, C. Mathieu. Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity.Endocrinol Metab Clin North Am . 46(4),1061–1094 (2017) Abstract/FREE Full Text
  10. W.B Grant, H. Lahore, S. L. McDonnell, C. A. Baggerly, C. B. French, J. L. Aliano, H. P. Bhattoa. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients . 12, 988. (2020) Abstract/FREE Full Text
  11. Hoang-Anh Nguyen. Vitamin D and SARS-CoV-2. Swiss Medical Weekly . (2020) Abstract/FREE Full Text
  12. M. Á. Jiménez-Sousa, I. Martínez, L.M. Medrano, A. Fernández-Rodríguez, & S. Resino (2018). Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease. Frontiers in immunology, 9, 458.   Abstract/FREE Full Text
  13. C. Annweiler et al. (2020) COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial). ClinicalTrials.gov [Ongoing] Abstract/FREE Full Text
  14. M. J Castillo et al. (2020) Vitamin D on Prevention and Treatment of COVID-19 (COVITD-19). ClinicalTrials.gov [Ongoing] Abstract/FREE Full Text
  15. M.Z. Tay, C.M. Poh, L.  Rénia,  et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol (2020).   Abstract/FREE Full Text